# Cardiotoxicities in Patients Receiving BTKi

> **NCT05521178** · — · WITHDRAWN · sponsor: **Dana-Farber Cancer Institute**

## Conditions studied

- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma

## Interventions

- **DIAGNOSTIC_TEST:** Electrocardiogram
- **DIAGNOSTIC_TEST:** Echocardiogram
- **DIAGNOSTIC_TEST:** Cardiac magnetic resonance imaging
- **DEVICE:** Mobile cardiac telemetry
- **DIAGNOSTIC_TEST:** Blood pressure monitoring
- **DIAGNOSTIC_TEST:** Blood draw

## Key facts

- **NCT ID:** NCT05521178
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-05
- **Primary completion:** 2026-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding for study was withdrawn
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05521178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05521178, "Cardiotoxicities in Patients Receiving BTKi". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05521178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*